Success Story: NIW Approved for Biochemistry Researcher Advancing Cancer and Metabolic Disease Research
Client’s Testimonial:
"Chen Immigration Attorneys have been incredibly helpful from start to finish, providing exceptional resources that clearly explain every required step and form. Their comprehensive “Client Packet” breaks down complex legal requirements into easily digestible information—which is highly comforting when navigating the immigration process with no prior legal background. While the overall timeline is naturally dependent on a client’s response, the team does a fantastic job of maintaining proactive communication to keep the preparation forward efficiently. I highly recommend their services!"
On June 16th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Clinical Services Associate in the Field of Biochemistry (Approval Notice).
General Field: Biochemistry
Position at the Time of Case Filing: Clinical Services Associate
Country of Origin: Mexico
State of Residence at the Time of Filing: Arizona
Approval Notice Date: June 16th, 2026
Processing Time: 2 months, 24 days (Premium Processing Upgrade Requested)
Case Summary:
Cancer and metabolic diseases continue to create major public health and economic burdens in the United States and worldwide. For this Mexican biochemistry researcher, who earned a Ph.D. in biochemistry, the proposed endeavor focused on developing integrative therapeutic strategies to uncover and characterize novel biomarkers and post-translational modifications. The petition described her continued work on protein interaction mechanisms, biomarker testing, and disease-related signaling pathways with applications that support improved diagnostic precision and therapeutic outcomes in cancer and metabolic diseases.
Research Contributions in Biochemistry
The client’s research has focused on biomolecular mechanisms of disease, protein interactions, cancer biology, metabolic disease, and therapeutic development. Her work has contributed to methods for understanding chitosan biopolymers in disease management, improving the precision of aloin quantification, and identifying mechanisms connected to mitochondrial dynamics and cancer metastasis. These contributions support better disease characterization, biomarker development, and more targeted treatment strategies.
Academic Contributions and Recognition
The client’s record included 10 peer-reviewed journal articles, 1 first-authored conference abstract, and 265 citations. Two of her papers ranked among the top 20% most-cited Molecular Biology & Genetics articles for their publication years.
We demonstrated the client’s significance through her degree, current biotechnology-related employment, publication record, citation influence, highly ranked publication venues, and documented reliance on her findings by independent researchers. It also emphasized that her work had influenced studies involving biodegradable drug delivery systems, aloe-based hydrogel development, mitochondrial and peroxisomal fission, protein transport, and cancer-related molecular mechanisms.
NIW Approval and Outlook
The I-140 NIW petition was filed on March 23rd, 2026, later upgraded to Premium Processing, and approved on June 16th, 2026. The approval recognized the national importance of the client’s work in biochemistry, particularly her research on biomarkers, post-translational modifications, protein interaction mechanisms, cancer biology, and metabolic disease.
This outcome supports the client’s continued efforts to advance biomarker research, diagnostic precision, therapeutic innovation, and improved treatment strategies for cancer and metabolic diseases in the United States.